Bibliography
- Wenzel SE, Westcott JY, Smith HR, Larsen GL. Spectrum of prostanoid release after bronchoalveolar allergen challenge in atopic asthmatics and in control groups. An alteration in the ratio of bronchoconstrictive to bronchoprotective mediators. Am Rev Respir Dis 1989;139(12):450-7
- Coleman RA, Smith WL, Narumiya S. International union of pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes. Pharmacol Rev 1994;46(2):205-29
- Hirai H, Tanaka K, Yoshie O, Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2. J Exp Med 2001;193(2):255-61
- Sawyer N, Cauchon E, Chateauneuf A, Molecular pharmacology of the human prostaglandin D2 receptor, CRTH2. Br J Pharmacol 2002;137(8):1163-72
- Ulven T, Kostenis E. Novel CRTH2 antagonists: a review of patents from 2006 to 2009. Expert Opin Ther Path 2010;20(11):1505-30
- Norman P. DP2 receptor antagonists in development. Expert Opin Investig Drugs 2010;19(8):947-61
- Parnes J, Banfield C, Chow V, Multiple-dose study of AMG853 in healthy adults: Safety and pharmacokinetics [Abstract 1165]. European Respiratory Society Annual Congress; 18 – 22 September 2010; Barcelona
- Barnes N, Pavord I, Chuchalin A, A randomized, double-blind, placebo-controlled study of the CRTH2 antagonist OC000459 in moderate persistent asthma. Clin Exp Allergy. 15 July 2011; [Epub ahead of print]
- Amira Pharmaceuticals press release 30 June 2009 Amira Pharmaceuticals Announces Initial Positive Phase 1 Clinical Data for AM211, A Novel Product Candidate for the Treatment of respiratory Disease Results
- Amira Pharmaceuticals press release 3 December 2009 Amira Pharmaceuticals Announces Initial Positive Phase I Clinical Data for AM461, A Back-Up to Amira's Lead DP2 Antagonist, AM211
- Amira Pharmaceuticals, Inc. Antagonists of PGD2 receptors. WO2009061676; 2009
- Amira Pharmaceuticals, Inc. Antagonists of Prostaglandin D2 receptors. WO2009108720; 2009
- Amira Pharmaceuticals, Inc. Antagonists of Prostaglandin D2 receptors. WO2010003127; 2010
- Amira Pharmaceuticals, Inc. Heterocyclic Antagonists of Prostaglandin D2 receptors. WO2010057118; 2010
- Stearns BA, Baccei C, Bain G, Novel tricyclic antagonists of the prostaglandin D2 receptor DP2 with efficacy in a murine model of allergic rhinitis. Bioorg Med Chem Lett 2009;19(16):4647-51
- Stebbins K, Broadhead AR, Baccei CS, Pharmacological blockade of the DP2 receptor inhibits cigarette smoke-induced inflammation, mucus cell metaplasia and epithelial hyperplasia in the mouse lung. J Pharmacol Exp Ther 2010;332(3):764-75
- Stebbins KJ, Broadhead AR, Correa LD, Therapeutic efficacy of AM156, a novel prostanoid DP2 receptor antagonist, in murine models of allergic rhinitis and house dust mite-induced pulmonary inflammation. Eur J Pharmacol 2010;638(1-3):142-9
- Scott JM, Baccei C, Bain G, Discovery and optimization of a biphenylacetic acid series of prostaglandin D2 receptor DP2 antagonists with efficacy in a murine model of allergic rhinitis. Bioorg Med Chem Lett 2011;21(21):6608-12
- Bain G, Lorrain DS, Stebbins KJ, Pharmacology of AM211, a potent and selective prostaglandin D2 receptor type 2 antagonist that is active in animal models of allergic inflammation. J Pharmacol Exp Ther 2011;338(1):290-301
- Amira Pharmaceuticals press release 26 May 2010 Amira announces Second DP2 antagonist Patent Grant in the United Kingdom
- Amira Pharmaceuticals press release 6 January 2009 Amira announces the successful completion of GLP toxicity studies for a novel DP2 antagonist. Lead candidate on track for IND submission first half of 2009
- Luker T, Bonnert R, Brough S, Substituted indole-1-acetic acids as potent and selective CRTh2 antagonists-discovery of AZD1981. Bioorg Med Chem Lett 2011;21(21):6288-92